Technology is transforming how clinical trials are run. A panel during MedCity News’ INVEST Digital Health conference discussed the tech trends shaping the design and execution of drug studies.
Medable recently launched a software solution to shorten the launch times for decentralized vaccine trials. The company says the software can reduce trial deployment timelines from more than 12 weeks on average to as short as five weeks.
As life science companies seek to boost clinical trial participation, eConsent forms can pose a stumbling block. A white paper by Medable shares some insights on how companies can leverage eConsent to improve clinical trial recruitment and retention.
A recent webinar by Medable discussed steps it's taking to improve clinical trial design through decentralized clinical trials
As life science companies seek to boost clinical trial participation, eConsent forms can pose a stumbling block. A white paper by Medable shares some insights on how companies can leverage eConsent to improve clinical trial recruitment and retention.
The speed of Covid-19 vaccine trials should inspire the pharmaceutical and medical device industries to accelerate its clinical testing, according to Shweta Maniar, Google Cloud’s director for healthcare and life sciences. She argued that harnessing real-world data will make faster clinical trials achievable for all therapeutics and devices, possibly even eliminating the need to recruit a placebo arm.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Join us tomorrow for a webinar sponsored by Medable as we explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
A webinar sponsored by Medable will explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
CVS MinuteClinic providers will use Medable’s software platform to improve patient access, engagement and retention during clinical trials. Meanwhile, Thermo Fisher Scientific and Medidata Acorn AI announced a collaboration to develop an application that combines patient recruitment and site performance data for clinical trials.
Medable recently raised $304 million, its fourth funding round in the past two years. The company’s software can be used to virtually consent patients into clinical trials and run telehealth visits as part of a trial.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Covid-19 pandemic is altering behavior and fueling demand for remote technologies in clinical trials with Medable, a company in the clinical trial software space, looking to capitalize.
For the second year, MedCity News is partnering with the New Orleans Business Alliance to host an executive summit that focuses on population health and highlights where innovation and investment are occurring in the field.
In a interview, an executive from Medable said patients will likely demand to have the choice of whether to show up at trial sites or participate in studies remotely. The Covid-19 pandemic has accelerated a trend toward decentralized trials that was already underway before it began.
Late last month, Medable and LabCorp CRO Covance signed a deal to accelerate adoption of decentralized trials, a trend that has been helped along as Covid-19 has created challenges to conducting trials dependent on traditional brick-and-mortar sites.
A panel discussion at the upcoming MedCity INVEST meeting in Chicago will look at real-world applications of blockchain technology in healthcare and biopharma.
